About Theraplant
Theraplant is a Healthcare company based in Watertown (United States) founded in 2014 by Dan Emmans, and was acquired by Greenrose Acquisition Corp in March 2021. Cannabis-based products including flowers, vapes, and concentrates are developed. Theraplant has raised $7 million across 1 funding round from investors including Greenrose Acquisition Corp. Its chief executive, as recorded, is Ethan Ruby. Theraplant offers products and services including Flower, Vapes, Premium Concentrates, Topicals, and Ingestibles. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Therapeutics and Diversified.
Company details
Theraplant was established in 2014 in Watertown, United States, within the cannabis sector. A range of products is developed by the company, encompassing flowers, pre-rolls, vapes, concentrates, topicals, and injectables across sativa, hybrid, indica, and CBD variants. Operations center on product development for medical and recreational use, with leadership provided by founder Dan Emmans and CEO Ethan Ruby. The domain theraplant.com is utilized for online presence.
- Headquarters Watertown, United States
- Founders Dan Emmans
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website theraplant.com
- Social LinkedIn X Facebook Instagram
- Acquired by Greenrose Acquisition Corp (Mar 2021)
- Total Equity Funding$7M (USD)
in 1 rounds
- Latest Funding Round$7M (USD), Series A
May 2014
- Investors
- Acquired byGreenrose Acquisition Corp
(Mar 2021)
Products & Services of Theraplant
Theraplant offers a comprehensive portfolio of products and services, including Flower, Vapes, Premium Concentrates, Topicals, and Ingestibles.
Cultivated strains for medicinal effects and patient relief
CO2 extracted oils for targeted cannabis delivery
Refined cannabis concentrates for potent therapeutic use
THC and CBD infused products for muscle and skin relief
Capsules and drops for oral cannabis consumption
Funding Insights of Theraplant
Theraplant has successfully raised a total of $7M through 1 strategic funding round. The most recent funding activity was a Series A round of $7 million completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7M
- Total Rounds 1
- Last Round Series A — $7M
- First Round $7M
(May 2014)
All 1 funding rounds of Theraplant with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2014 | $7M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Theraplant
Theraplant has secured backing from 1 investor. Prominent investors backing the company include Greenrose Acquisition Corp.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Blank check company focused on multiple sectors | 2019 | greenrosecorp.com | Amityville, United States |
Investor details for Theraplant
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Theraplant
7 people are tracked at Theraplant (4 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Dan Emmans | Founder | Leadership |
Ethan Ruby | CEO | Leadership |
David Goldburg | CEO | Leadership |
Julie Dubocq | Chief Financial Officer | Leadership |
Nicole Benoit | Cultivation Manager | Team |
Andrew Turro | Purchasing & IT Administrator | Team |
Joshua Dennis | Cultivation Supervisor (flower) | Team |
Complete people profiles for Theraplant
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Theraplant
3 dated milestones of Theraplant across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Theraplant is founded.
- Funding First funding round of $7.0M.
- Exit Acquired by Greenrose Acquisition Corp.
Web traffic of Theraplant
The website of Theraplant (theraplant.com) receives about 3.1K visits a month.
- Monthly visits3.1K
▼ 17.4% vs previous month
Websites whose visitors overlap most with Theraplant. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
davisislandspharmacy.com | davisislandspharmacy.com | 100% | #6,967,494 | – | |
| transdermalinc.com | 99% | View details | |||
onefarm.com | onefarm.com | 90% | #2,870,263 | – | |
one59ga.com | one59ga.com | 89% | #3,099,425 | – | |
| stillriverwellness.com | 80% | #825,979 | View details |
Top companies in Cannabis Health Tech Ecosystem
3 companies that operate in the same segment as Theraplant (Cannabis Health Tech Ecosystem) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Online marketplace platform for cannabis traders | 2015 | New York, New York, United States | USD 195.4 M | |||
Loyalty and marketing solutions for cannabis dispensaries are provided. | 2012 | West Palm Beach, Florida, United States | USD 25.79 M | USD 22.83 M | ||
An online marketplace for cannabis products is operated. | 2017 | Bend, Oregon, United States | USD 603 M | 469 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Theraplant
Complete news archive for Theraplant
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theraplant
Theraplant was founded in 2014.
Theraplant is headquartered in Watertown, United States.
Ethan Ruby is the CEO of Theraplant, as recorded in our data.
Theraplant is a funded company, having raised a total of $7M across 1 funding round to date. The company's 1st funding round was a Series A of $7M, raised on May 2014.
Theraplant was established in 2014 in Watertown, United States, within the cannabis sector. A range of products is developed by the company, encompassing flowers, pre-rolls, vapes, concentrates, topicals, and injectables across sativa, hybrid, indica, and CBD variants. Operations center on product development for medical and recreational use, with leadership provided by founder Dan Emmans and CEO Ethan Ruby. The domain theraplant.com is utilized for online presence.
Theraplant offers Flower, Vapes, Premium Concentrates, Topicals, and Ingestibles.
Theraplant has 1 investor. Key investors include Greenrose Acquisition Corp.
Yes. Theraplant was acquired by Greenrose Acquisition Corp in March 2021.